ReviewFrontiers in pharmacology2019
Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases.
Rafael M da Costa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled itcites it